|
|
|
|
|
Mission
Resources
NewsLeadership and Team membersChairs:
Daniel Martins-de-Souza, Ph.D University of Campinas, Sao Paulo, Brazil
Melanie Föcking, Ph.D Royal college of surgeons, Dublin, Ireland Executive Committee members:
Katrin Marcus, Ph.D Ruhr University, Bochum, Germany
Oliver Schubert, MD, Ph.D University of Adelaide, Adelaide, Australia
Peter Nilsson, Ph.D KTH - Royal Institute of Technology, Stockholm, Sweden
Robert Mccullumsmit, MD, Ph.D University of Toledo, Toledo, USA |
The Human Brain Proteome Project (HBPP) gathers neuroproteomics researchers working in the fields of neuroscience, neurology, psychiatry, neurosurgery, and brain oncology aiming to explore the role of proteins in brain development, health, and disease. Launched in 2003 and redesigned in 2015, HBPP provides a forum for scientific exchange on large-scale and targeted state-of-the-art proteome studies on human brain, brain-related body fluids such as CSF, pre-clinical models, and clinical translation initiatives. Current lines of work: HBPP participants focus on two major areas:
Neuroproteomic methods are applied to brain tissue, cultured cells and organoids, cerebrospinal fluid (CSF), and peripheral blood. Exploring brain biology includes the investigation of the proteome associations with neurodegenerative disorders (e.g., the dementias, movement disorders), psychiatric disorders (e.g., schizophrenia, bipolar disorder, depressive disorder), CNS cancers and traumatic brain injury. The HBPP promotes the connection of neuroproteomic scientists across pre-clinical and clinical fields, fosters new collaborations, and actively encourages the inclusion of young investigators. Our well-established annual HBPP workshop has been travelling around the world to capture, congregate, and connect the international neuroproteomics community. HBPP membership: If you would like to become a member of HUPO-HBPP complete the attached Membership Form. | Announcements & upcoming eventsVirtual Workshop in Neuroproteomics 18-19 May 2021
|
